Predictive value of symptoms for quality of life in first-episode schizophrenia

Nordic Journal of Psychiatry

Volumn 67, Issue 3, 2013, Pages 153-158

  Chugh, Preeta Kaur ^a,b   Rehan, Harmeet S ^a   Unni, K E S ^a   Sah, Ravinder K ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

^b G B PANT HOSPITAL   (India)

Author keywords

First episode; PANSS; Psychopathology; Quality of life; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PREDICTIVE VALUE; PROSPECTIVE STUDY; QUALITY OF LIFE; WELLBEING;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84878081392     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2012.687768     Document Type: Article

References (35)

1. Naber D, Moritz S, Lambert M, Pajonk FG, Holzbach R, Mass R, et al. Improvement of schizophrenic patients ' subjective well-being under atypical antipsychotic drugs. Schizophr Res 2001;50:79-88.
2. Voruganti LN, Awad AG. Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res. 2002;56:37-46.
3. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:1569-85.
4. Eack SM, Newhill CE. Psychiatric Symptoms and Quality of Life in Schizophrenia: A Meta-Analysis. Schizophr Bull 2007;33:1225-37.
5. The WHOQOL Group. The World Health Organization Quality of Life Assessment (the WHOQOL): position paper from the World Health Organisation. Soc Sci Med 1995;41:1403-9.
6. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 1992;30:473-83.
7. Kind P. The EuroQoL instrument: an index of HRQOL. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. Philadelphia: Lippincott-Raven; 1996. p. 191-201.
8. Heinrichs DW, Hanlon TE, Carpenter WT. The quality of life scale: an instrument for rating the schizophrenic defi cit syndrome. Schizophr Bull 1984;10:388-98.
9. Lehman AF. A Quality of Life Interview for the chronically mentally ill (QOLI). Eval Prog Planning 1988;11:51-62.
10. Oliver JPJ, Huxley PJ, Priebe S, Kaiser W. Measuring the quality of life of severly mentally ill people using the Lancashire Quality of Life Profi le. Soc Psychiatry Psychiatr Epidemiol 1997;32:76-83.
11. Auquier P, Simeoni MC, Sapin C, Reine G, Aghababian V, Cramer J, et al. Development and validation of a patient-based health related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res 2003;63:137-49.
12. Law CW, Chen EY, Cheung EF, Chan RC, Wong JG, Lam CL, et al. Impact of untreated psychosis on quality of life in patients with fi rst-episode schizophrenia. Qual Life Res 2005;14:1803-11.
13. Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996;94:118-24.
14. Hofer A, Baumgartner S, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA, et al. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur Psychiatr 2005;20:386-94.
15. Bamiso Makanjuola A, Ademola Adeponle B, Ayodele Obembe O. A comparison of quality-of-life in schizophrenia and affective disorder patients in a Nigerian tertiary hospital. Transcult Psychiatry 2007;44:65-78.
16. Wegener S, Redoblado-Hodge MA, Lucas S, Fitzgerald D, Harris A, Brennan J. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in fi rst-episode psychosis. Aust New Zeal J Psychiatr 2005;39:487-92.
17. Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE. Quality of life in schizophrenia: contribution of anxiety and depression. Schizophr Res 2001;51:171-80.
18. Dickerson FB, Ringel NB, Parente F. Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand 1998;98:124-7.
19. Meijer CJ, Koeter MW, Sprangers MA, Schene AH. Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2009;44:361-8.
20. Konig HH, Roick C, Angermeyer MC. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders. Eur Psychiatry 2007;22:177-87.
21. Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL. Subjective and objective quality of life in schizophrenia. Schizophr Res 2008;98:201-8.
22. Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia. Progr Neuro Psychopharmacol Biol Psychiatr 2007;31:703-12.
23. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in fi rst-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatr 1998;155:196-201.
24. Wheeler A. Sociodemographic, functional and clinical correlates in outpatients with schizophrenia: comparison with affective disorders. Aust New Zeal J Psychiatr 2007;41:809-18.
25. The ICD-10 Classifi cation of Mental and Behavioural disorders: Diagnostic Criteria for Research. World Health Organization, Geneva 1994:64-9.
26. Skevington SM, Lotfy M, O'Connell KA, WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international fi eld trial. A report from the WHOQOL group. Qual Life Res 2004;13:299-310.
27. Saxena S, Chardiramani K, Bhargava R. WHO QOL-Hindi. A questionnaire for assessing quality of life in health care setting in India. Natl Med J India 1998;11:160-6.
28. K ay SR, Opler LA, Fiszbein A. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull 1987;13:261-76.
29. Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenics. Psychiatry Res 1988;23:99-110.
30. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardization. Br J Psychiatry Suppl 1989;7:59-67.
31. Wieselgren IM, Lindstrom E, Lindstrom LH. Symptoms at index admission as predictor for 1-5 year outcome in schizophrenia. Acta Psychiatr Scand 1996;94:311-9.
32. M cGlashan TH, Fenton WS. The positive-negative distinction in schizophrenia: review of natural history validators. Arch Gen Psychiatr 1992;49:63-72.
33. Karow A, Moritz S, Lambert M, Schoder S, Krausz M. PANSS syndromes and quality of life in schizophrenia. Psychopathology 2005;38:320-6.
34. Kulhara P. Outcome of schizophrenia: some transcultural observations with particular reference to developing countries. Eur Arch Psychiatr Clin Neurosci 1994;244:227-35.
35. Gasquet I, Haro JM, Novick D, Edgell ET, Kennedy L, Lepine JP, SOHO Study Group. Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Int Clin Psychopharmacol 2005;20:199-205.